Chapter 3: Toxic Effects of Drugs

Toxic Effects of Drugs on the Toxic Effects of Drugs systematically defines and explores the various mechanisms through which pharmaceutical agents can cause undesired, unpleasant, or potentially dangerous adverse drug reactions (ADRs). ADRs are categorized based on their mechanism, beginning with primary actions, which are simply exaggerated extensions of the drug's desired therapeutic effect, often resulting from dosage issues or individual patient response. Next are secondary actions, which are unavoidable effects unrelated to the drug's therapeutic goal, such as the drowsiness caused by certain antihistamines. The chapter emphasizes hypersensitivity, an excessive individual responsiveness to a drug's effects, which may stem from underlying pathologies that impair drug excretion or accumulation. Distinct from hypersensitivity is a true drug allergy, where the body forms antibodies to the drug, triggering an immune response upon subsequent exposure; these allergic reactions fall into four main classifications: anaphylactic, cytotoxic, serum sickness, and delayed reactions. Significant attention is paid to drug-induced tissue and organ damage, which includes severe dermatological reactions (ranging from simple rashes to potentially fatal exfoliative dermatitis and Stevens-Johnson syndrome), inflammation of the mucous membranes known as stomatitis, and superinfections that arise when drugs (especially antibiotics) destroy the body's protective normal flora, allowing opportunistic organisms to flourish. Furthermore, drugs may cause blood dyscrasia (bone marrow suppression) by affecting rapidly dividing cells. Toxicity can manifest as serious liver injury due to the first-pass effect and metabolism of irritating metabolites, or as renal injury where drug molecules plug the capillary network of the glomerulus or irritate the renal tubule. Systemic effects include dangerous alterations in glucose metabolism (hypoglycemia or hyperglycemia) and critical electrolyte imbalances, particularly in potassium, leading to hypokalemia or hyperkalemia, both of which necessitate careful cardiac monitoring. The chapter also details sensory and neurological complications, such as ocular damage (potentially leading to blindness), auditory damage (causing tinnitus or hearing loss), general central nervous system (CNS) effects, atropine-like (anticholinergic) effects, Parkinson-like syndrome, and the potentially fatal Neuroleptic Malignant Syndrome (NMS). Finally, the risk of teratogenicity, where drug exposure in utero can lead to fetal death or congenital defects, is highlighted, requiring a careful weighing of benefits versus risks for pregnant patients.